Motley Fool Money cover image

"The healthiest business on the U.S. stock market"

Motley Fool Money

00:00

Pharma Finances: COVID-19 and Beyond

This chapter examines the financial maneuvers of Abbott Laboratories, Moderna, and Pfizer in the wake of COVID-19 sales revenues. It highlights their investments in research and development, innovative drug pipelines, and strategic focuses on various diseases, while assessing which company is likely to maximize its growth potential.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app